Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARCUS ANDREW OWEN

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1972524429
CMS profile
134930
Location
MURFREESBORO, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$29,864.53

96 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARCUS ANDREW OWEN

NPI 1972524429 · CMS profile ID 134930

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

MURFREESBORO, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972524429?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARCUS ANDREW OWEN, NPI 1972524429, CMS profile ID 134930. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972524429?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MARCUS ANDREW OWEN, NPI 1972524429, CMS profile ID 134930. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972524429?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MARCUS ANDREW OWEN, NPI 1972524429, CMS profile ID 134930, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1972524429?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

96 matching records · $29,864.53 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 96 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–96 of 96.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $1,575.0007/06/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818641137 CMS
AbbVie Inc. $2.9807/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458687 CMS
Janssen Biotech, Inc. $20.2806/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788876493 CMS
Allergan, Inc. $12.3506/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792896183 CMS
AbbVie Inc. $13.7006/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458681 CMS
Janssen Scientific Affairs, LLC $750.0006/15/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788876497 CMS
Amgen Inc. $2,000.0006/10/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825576607 CMS
AbbVie Inc. $2.8105/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458675 CMS
E.R. Squibb & Sons, L.L.C. $17.4805/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783516433 CMS
Novartis Pharmaceuticals Corporation $10.6605/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134885 CMS
Novartis Pharmaceuticals Corporation $106.8905/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134857 CMS
AbbVie Inc. $6.3305/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458669 CMS
Amgen Inc. $19.2105/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825576587 CMS
Mallinckrodt Hospital Products Inc. $16.9804/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845372525 CMS
Lilly USA, LLC $900.0004/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818585455 CMS
Novartis Pharmaceuticals Corporation $14.1904/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134881 CMS
AbbVie Inc. $4.0104/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458663 CMS
GlaxoSmithKline, LLC. $14.5204/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801976259 CMS
UCB, Inc. $26.7704/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807334427 CMS
AbbVie Inc. $4.6804/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458657 CMS
Genentech USA, Inc. $18.3204/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835944601 CMS
AbbVie Inc. $4.6803/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458651 CMS
Hikma Pharmaceuticals USA $17.5403/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 808542073 CMS
AbbVie Inc. $16.1703/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458645 CMS
Lilly USA, LLC $900.0003/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818599097 CMS
AbbVie Inc. $4.6603/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458639 CMS
Lilly USA, LLC $17.8603/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818641139 CMS
E.R. Squibb & Sons, L.L.C. $19.0403/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783516387 CMS
Novartis Pharmaceuticals Corporation $9.8203/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134877 CMS
Amgen Inc. $17.0903/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825576583 CMS
Novartis Pharmaceuticals Corporation $52.2003/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134853 CMS
AbbVie Inc. $4.6603/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458633 CMS
Radius Health, Inc. $11.4203/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830733323 CMS
Novartis Pharmaceuticals Corporation $11.0802/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134873 CMS
AbbVie Inc. $3.7902/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458627 CMS
Amgen Inc. $600.0002/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825576603 CMS
Novartis Pharmaceuticals Corporation $2.9001/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134869 CMS
Lilly USA, LLC $1,800.0001/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818632379 CMS
AbbVie Inc. $1,200.0001/25/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458621 CMS
Lilly USA, LLC $18.2501/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818664495 CMS
Amgen Inc. $18.1801/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826385735 CMS
Amgen Inc. $18.1801/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826385737 CMS
Novartis Pharmaceuticals Corporation $13.9201/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134865 CMS
Amgen Inc. $8.7601/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825576599 CMS
AbbVie Inc. $15.3301/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795458617 CMS
Novartis Pharmaceuticals Corporation $1.7501/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813134861 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $67,035.18 246
PY2020 $35,593.10 180
PY2021 $29,864.53 96
PY2022 $32,129.38 132
PY2023 $30,517.35 105
PY2024 $69,818.39 153
PY2025 $58,948.04 180

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $259,986.98 8
PY2024 Recipient $20,109.16 2
PY2024 Principal investigator $9,718.82 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 UCB SA $15,924.31 10/10/2025 Non-covered Recipient Entity
ARIZONA ARTHRITIS AND RHEUMATOLOGY RESEARCH
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 1246658036
Principal investigator 1 Amgen Inc. $81,785.65 07/16/2025 Non-covered Recipient Entity
ARIZONA ARTHRITIS AND RHEUMATOLOGY RESEARCH
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246639299
Principal investigator 1 Amgen Inc. $10,000.00 06/20/2025 Non-covered Recipient Entity
ARIZONA ARTHRITIS AND RHEUMATOLOGY RESEARCH PLLC
A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjgren's Syndrome (SS) No dispute reported 06/30/2026 1246639235
Principal investigator 1 Amgen Inc. $49,424.55 04/16/2025 Non-covered Recipient Entity
ARIZONA ARTHRITIS AND RHEUMATOLOGY RESEARCH PLLC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246639253
Principal investigator 1 UCB SA $13,069.05 02/05/2025 Non-covered Recipient Entity
MURFREESBORO MEDICAL CLINIC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 1246657632
Principal investigator 1 Eli Lilly and Company $49,848.00 01/28/2025 Non-covered Recipient Entity
ARIZONA ARTHRITIS AND RHEUMATOLOGY RESEARCH
EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSA) No dispute reported 06/30/2026 1187874925
Principal investigator 1 Eli Lilly and Company $595.00 01/27/2025 Non-covered Recipient Entity
AARA CLINICAL RESEARCH
EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSA) No dispute reported 06/30/2026 1187875677
Principal investigator 1 Amgen Inc. $39,340.42 01/17/2025 Non-covered Recipient Entity
MURFREESBORO MEDICAL CLINIC WESTLAWN
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246644930